Skin Boosters Market Report Scope & Overview:

The Skin Boosters Market was estimated at USD 1.40 Billion in 2025 and is expected to reach USD 4.30 Billion by 2035, growing at a CAGR of 11.89% from 2026 to 2035.

The increase in the number of people interested in the use of minimally invasive skin enhancement procedures such as those designed to hydrate the skin, increase its elasticity, and improve its texture is fuelling the rapid expansion of the skin boosters market on a worldwide scale. The use of such products is increasingly motivated by consumer awareness, the existence of an ageing population globally, and an increase in the practice of preventative skincare care. New developments in terms of formulation, such as hyaluronic acid-based treatments, polydeoxyribonucleotides, and exosomes, have greatly improved clinical results and broaden the scope of treatment. Global expansion of medspa services and the increasing role played by social media platforms in influencing aesthetic preferences are helping to ensure future growth. The ever-increasing popularity of achieving youthful looking skin through skin boosting treatments both professionally and at home continues to motivate consumers to try these products.

It was reported in June 2025 by Allergan Aesthetics, an AbbVie company, that they continue expanding their FDA approved skin booster and hyaluronic acid-based products in the United States market.

Market Size and Forecast

• Market Size in 2026E: USD 1.56 Billion

• Market Size by 2035: USD 4.30 Billion

• CAGR: 11.89% from 2026 to 2035

• Fastest Growing Region: Asia Pacific

• Largest Region: North America

To Get more information On Skin Boosters Market - Request Free Sample Report

Skin Boosters Market Trends

• The increasing consumer inclination towards non-invasive aesthetic treatments, which deliver natural results and have a faster recovery period, is expected to boost the adoption rate for skin booster products.

• The use of innovative regenerative ingredients such as PDRN, exosomes, and cross-linked hyaluronic acid is increasing the applications and effectiveness of skin boosters.

• The increasing role of social media and the influence of cosmetic influencers is raising awareness and acceptance of non-surgical facial rejuvenation treatments among consumers.

• The growing number of medspas and aesthetic clinics in North America, Europe, and the Asia-Pacific regions will drive procedure uptake in these markets.

• The rising demand for preventive anti-aging solutions from male customers and the young population segment is increasing the customer base of skin boosters.

U.S. Skin Boosters Market Size Outlook:

The U.S. skin boosters market was valued at USD 0.36 Billion in 2025 and is expected to reach USD 1.08 Billion by 2035, growing at a CAGR of 11.61% from 2026 to 2035.

The U.S. skin boosters market is positively influenced by North America’s well-developed environment of medspas, dermatology clinics, and aesthetic treatment options approved by the Food & Drug Administration (FDA). Increased awareness levels among consumers about minimally invasive cosmeceutical procedures, efficient healthcare infrastructure, and insurance coverage for certain dermatological treatment modalities drive the domestic market. The availability of clinical evidence-based hyaluronic acid and PDRN skin boosters from established manufacturers makes them available to patients both in urban and suburban markets. Increased preference for natural-looking aesthetic solutions in younger generations of millennials and Generation Z drives the emergence of a new generation of customers among skin boosters patients.

The leading position in the U.S. skin boosters market is held by AbbVie, whose Allergan Aesthetics business unit offers an extensive range of hyaluronic acid skin boosters and dermal fillers.

Skin Boosters Market Segment Analysis

• By Type, Mesotherapy segment dominated the Skin Boosters Market in 2025 with approximately 59.6% share; Micro-needle segment fastest growing.

• By Ingredient, Hyaluronic Acid (HA) segment dominated the Skin Boosters Market in 2025 with approximately 55.4% share; PDRN segment fastest growing.

• By Gender, Female segment dominated the Skin Boosters Market in 2025 with approximately 74.15% share; Male segment fastest growing.

• By End Use, Medspas segment dominated the Skin Boosters Market in 2025; Dermatology Clinic segment fastest growing.

By Type, Mesotherapy segment dominates the skin boosters market, Micro-needle segment expected to grow fastest

Mesotherapy segment dominated the skin boosters market in 2025 with approximately 59.6% share owing to its long-standing clinical track record, minimally invasive application method, and effectiveness in delivering active ingredients directly into the mesodermal layer of the skin. The procedure is extensively used in dermatology clinics as well as medspas all around the world thanks to practitioners' experience with the method, educational programs, and an abundance of available formulations. Mesotherapy's ability to help with such skin issues as hydration, fine lines, lack of glow, as well as early signs of aging, makes the procedure popular not only in the already established markets but also new ones. Opening a greater number of medspa locations in many regions all over the world contributes to the dominance of mesotherapy on the market.

Among different types of skin boosters, the micro-needle segment shows the fastest rate of growth thanks to the rising interest among younger customers, who prefer more discreet treatments, and popularity of home-use devices for micro-needling. With the micro-needle type of application, the active components of the skin booster can be delivered to the dermis layer in a controllable way without causing pain or requiring too much time for recovery after the procedure. Increasing use of social media in order to find out about micro-needling treatments, as well as greater trust in home aesthetic devices, speeds up the process of adoption among customers.

By Ingredient, Hyaluronic Acid (HA) segment dominates the skin boosters market, PDRN segment expected to grow fastest

Hyaluronic Acid (HA) segment dominated the skin boosters market in 2025 with approximately 55.4% market share due to its clinically proven effectiveness, strong safety profile, and widespread acceptance across medical aesthetic applications globally. HA is a naturally occurring molecule in the human body, which supports high patient acceptance and regulatory approval across multiple markets. The capacity of retaining sufficient levels of moisture in the skin along with its suitability for use with cross-linking technology to prolong the treatment period has earned hyaluronic acid the position of the core ingredient in the skin booster segment. Some of the popular products that include Restylane Skinboosters from Galderma and RHA Collection from Teoxane boast high physician and patient adherence, further reinforcing the dominance of HA in this product category.

The polydeoxyribonucleotides (PDRN) segment is the fastest growing segment in the skin booster market owing to the growing popularity of regenerative treatments among consumers and physicians who look for treatments for skin healing and regeneration beyond simple hydration and moisturizing of the dermis layer. Made from DNA extracted from salmon, PDRN activates adenosine receptors in the skin tissues which enhances the healing process and rejuvenates skin tissue cells. There is ample clinical evidence available about the effectiveness of PDRN in treating photodamage, acne scars, and early skin aging. The trend towards the adoption of clinically-proven biological ingredients in aesthetic treatments is expected to drive the adoption of PDRN further in skin rejuvenation products.

By End Use, Medspas segment dominates the skin boosters market, Dermatology Clinic segment expected to grow fastest

Medspas segment dominated the skin boosters market in 2025 due to the significant consumer demand for minimally invasive cosmetic procedures delivered in a relaxing, spa-like environment that combines clinical efficacy with a premium experiential setting. Medspas have proliferated rapidly across North America, Europe, and Asia Pacific, making skin booster treatments accessible to a broader consumer demographic beyond traditional clinical settings. Their capability of providing bundle treatments, loyalty program offerings, and an overall less formal consultation process makes skin boosters an appealing product option to first-time aesthetic treatment users. The expanding infrastructure of the medspa industry, which includes franchising systems and standardized treatment protocols, has ensured standard delivery of skin boosters and consistent procedure volume growth worldwide.

The Dermatology Clinic Segment has been the fastest-growing end-user segment in the skin boosters market owing to rising preference for evidence-based aesthetic treatment procedures that are supervised by board-certified dermatologists and plastic surgeons. In addition, the rise in the use of advanced skin boosters treatments such as combination therapy of skin boosters, PDRN, exosomes, and biostimulators is driving patients to visit dermatology clinics, which have greater knowledge in this area and provide approved skin boosters formulations. Further, the extension of insurance coverage of specific dermatology treatments in certain geographies is also encouraging patients to visit clinics.

Regional Insights:

North America Skin Boosters Market Insights

North America led the skin boosters market in 2025, holding approximately 33.6% of global revenue, supported by high consumer awareness of aesthetic procedures, a robust network of medspas and dermatology clinics, and strong FDA regulatory frameworks governing approved skin booster formulations. The United States dominates regional revenue, driven by high disposable incomes, strong social media influence on aesthetic treatment adoption, and a well-established physician aesthetic training ecosystem. Growing acceptance of preventive anti-aging treatments among younger demographics and increasing male consumer participation in aesthetic procedures are expanding the domestic patient base. Investment by leading companies including Allergan Aesthetics, Galderma, and Revance in expanding their North American commercial footprints is further supporting regional market leadership.

Get Customized Report as per Your Business Requirement - Enquiry Now

Europe Skin Boosters Market Insights

Europe skin boosters market is experiencing steady growth supported by strong medical aesthetic traditions, high consumer awareness of injectable treatments, and robust regulatory frameworks governing product safety and efficacy. The United Kingdom, France, Germany, and Italy are the leading markets, with well-established networks of aesthetic clinics and trained practitioners supporting consistent procedure volume. Growing consumer preference for natural-looking skin enhancement without the volumizing effects of traditional dermal fillers is positioning skin boosters as a preferred treatment category across European aesthetic markets. Leading European-origin brands including Teoxane Laboratories and Croma-Pharma maintain strong physician and patient loyalty across the continent's aesthetic treatment landscape.

Asia Pacific Skin Boosters Market Insights

It is estimated that Asia Pacific will be the fastest-growing segment in terms of CAGR at 12.70%, owing to the fast-growing middle classes, increasing demand for cosmetic treatments, and preference among consumers for youthful and glowing skin. South Korea acts not only as an important destination for such treatments but also plays an important role in innovations, as the leading companies in Korean aesthetic medicine such as Hugel, Medytox, and Caregen have become well-known internationally for the latest PDRN and HA-based skin booster solutions. Medical procedures in beauty treatments in countries like China, Japan, and India are showing increased trends in adoption owing to better living conditions and more confident urban consumers investing in their looks.

Middle East & Africa and Latin America Skin Boosters Market Insights

Skin boosters markets in the Middle East and Africa region and Latin America are experiencing a significant rise in demand for non-invasive cosmetic procedures, fueled by an increase in disposable income levels, better-equipped clinics in the region, and more influence by social media regarding beauty trends. Some of the major countries in the Middle East that will drive growth are the UAE and Saudi Arabia, with consumers being very enthusiastic about advanced and expensive aesthetic treatments as well as a growing population of urban consumers who care about their appearance. Brazil leads the market for Latin America with one of the highest numbers of people opting for cosmetic surgeries in the world.

Market Dynamics:

Growth Drivers: Increasing demand for minimally invasive aesthetic procedures is driving widespread adoption of skin booster treatments across global markets

The movement towards non-surgical methods that entail reduced downtime, fewer risks, and better aesthetics is the key factor driving the structural growth of the skin boosters market globally. Individuals have started demanding treatments that improve their skin quality on a cellular level rather than volumizing or restructuring their face. Hyaluronic acid-based skin boosters and innovative formulations such as PDRN and exosomes not only offer improved hydration and enhanced production of collagen in addition to improved skin texture but can also be easily performed in a short period of time. Increased visibility of these treatments on social media platforms in conjunction with user testimonials as well as educational content posted by professionals has led to increased consumer interest. Increased availability of medspas globally and growing knowledge among physicians about aesthetic medicine have also been contributing to the growth of the market.

Restraints: High treatment costs and limited insurance coverage are restricting skin booster adoption among price-sensitive consumer segments globally

The procedure of skin booster treatment itself requires considerable personal financial commitment from the consumer since each session will require several hundred or even several thousand dollars depending on the formula applied, the injection point chosen, and the geographical location. The requirement of multiple treatments to ensure longevity of the effects is also a reason why these procedures are unlikely to be used regularly by the price-sensitive demographic segment of consumers. Skin booster and other aesthetic treatment services in general are not covered under most health insurance plans, so all costs must be borne by the consumer. Moreover, there is a lack of trained professionals offering certified treatments in most emerging markets, thus contributing to concerns about the effectiveness and safety of these treatments.

Opportunities: Growing adoption of exosome-based and next-generation regenerative skin boosters is opening new premium market segments with significantly higher revenue potential

Exosome skin boosters are among the most promising new opportunities in the global market for aesthetic procedures. Initial scientific studies confirm that exosomes offer a better skin regeneration, less inflammation, and a quicker recovery process as compared to existing formulas, such as HA and PDRN. The emergence of regulations for a new class of biological ingredients allows companies working in aesthetics to conduct research and prepare exosome skin boosters for sale in key global markets. A premium product with the opportunity to charge significantly higher prices for procedures than for traditional skin boosters is an excellent revenue source for manufacturers and providers alike. Moreover, increasing consumer demand for scientifically proven, bioactive skincare creates favorable conditions for exosome products' sales before the mass adoption of the technology in the market.

Recent Developments:

• 2025: AbbVie's Allergan Aesthetics confirmed expansion of its U.S. skin booster portfolio, reinforcing its dominant position in the North American aesthetic injectables market and strengthening its leadership in FDA-approved hyaluronic acid-based aesthetic treatment formulations.

• 2025: Galderma expanded its Restylane Skinboosters product range in European and Asia Pacific markets, reflecting growing international demand for clinically validated hyaluronic acid-based skin booster treatments and strengthening the company's global aesthetic portfolio leadership.

• 2024: Hugel and Medytox continued expanding their PDRN and HA-based skin booster product portfolios in global export markets, capitalizing on the growing international recognition of Korean aesthetic medicine innovations and the rising global demand for regenerative skin treatments.

• 2024: RegenLab and Caregen advanced their regenerative skin booster research programs, investigating new combinations of PDRN, growth factors, and exosome technologies to develop next-generation formulations targeting deeper skin regeneration and longer-lasting aesthetic outcomes.

Skin Boosters Market Key Players are:

• Allergan Aesthetics (AbbVie)

• Galderma

• Teoxane Laboratories

• Merz Pharma

• Revance Therapeutics

• Laboratoires Filorga

• Croma-Pharma

• BioScience

• RegenLab

• Caregen

• Haohai Biological Technology

• Bloomage Biotechnology

• Cytocare (Revitacare)

• Anika Therapeutics

• Prollenium Medical Technologies

• Dermedics Laboratory

• Hugel

• Medytox

• IBSA Institut Biochimique

• Revive Pharma

Skin Boosters Market Report Scope: